{
    "SPADE_N_14023": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14023",
            "Peptide Name": "Bac2A (synthetic AMPs, Arg-rich; XXA, UCLL1c)",
            "Source": "Sequence variant of Bac2A, animal-derived, natural derivative",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "RLARIWWIRWAR",
            "Sequence Length": 12,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Antifungal",
                "Antifungal"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 1683.02,
            "PI": 12.0,
            "Hydrophobicity": -0.36,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Hancock RE, Hilpert K, Cherkasov A, Fjell C.2006",
                    "Reference": "Patent US9017656_",
                    "Title": "SMALL CATIONIC ANTIMICROBIAL peptides"
                }
            ],
            "Frequent Amino Acids": "RWA",
            "Absent Amino Acids": "CDEFGHKMNOPQSTUVY",
            "Basic Residues": 4,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 8,
            "Polar Residues": 6,
            "Positive Residues": 4,
            "Negative Residues": 0,
            "Net Charge": 4,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (58.33%) toBactenecinR: 33%; W: 25%.Activity: active against P. aeruginosa PAO1 (MIC 50 ug/ml), E. coli (MIC 17 ug/ml), S. typhimurium (MIC 34 ug/ml), S. aureus (MIC 17 ug/ml), S. epidermidis (MIC 4 ug/ml), E. faecalis ATCC29212 (MIC 17 ug/ml), and C. albicans (MIC 9 ug/ml).",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_13415",
                    "Similarity": 1.0,
                    "Sequence": "RLALRLALRALRAALRLA"
                },
                {
                    "SPADE_ID": "SPADE_UN_01836",
                    "Similarity": 1.0,
                    "Sequence": "RLARI"
                },
                {
                    "SPADE_ID": "SPADE_UN_21189",
                    "Similarity": 1.0,
                    "Sequence": "RLALRLALRALRAALRLA"
                }
            ]
        }
    }
}